Cohen & Steers Inc (CNS) could be a solid choice for investors given its recent upgrade to a Zacks Rank #2 (Buy). This upgrade primarily reflects an upward trend in earnings estimates, which is one of ...

Investment management firm Cohen & Steers (NYSE:CNS) will be reporting earnings this Thursday after market close. Here’s what ...

Cohen & Steers (CNS) has returned to investor attention after recent trading left the shares with a year-to-date total return of about a 3% decline and a 1-year total return of nearly a 21% decline.

Secondary CNS lymphoma happens when non-Hodgkin’s lymphoma spreads to the brain, spinal cord, or eyes. Its symptoms depend on the areas of the CNS that are affected. The outlook for people with this ...

CNS toxicity remains one of the leading causes of failure in drug development, yet it is rarely detected in preclinical ...